SAMDI Tech is looking forward to attending Discovery on Target in Boston, MA, October 17-20, 2022. The conference highlights advancements in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.
On Tuesday, October 18, Zachary Gurard-Levin, Ph.D., chief scientific officer of SAMDI Tech, and Katherine Jones, Ph.D., senior research leader of Charles River, will describe innovative tools to initiate and advance drug discovery efforts focused on PROTACs and Molecular Glues. Through a series of case studies, we will showcase a novel affinity selection mass spectrometry (ASMS) technique with distinct advantages over traditional approaches to accelerate hit finding efforts. Then we’ll describe medicinal chemistry efforts to advance leads toward functional modalities and highlight assays to validate target degradation in multiple models.
Tuesday, October 18
12:35 p.m. EDT
Accelerate the discovery of PROTACs and Molecular Glues from lead identification to protein degradation validation
Zachary Gurard-Levin, Ph.D.
Chief Scientific Officer, SAMDI Tech
Katherine Jones, Ph.D.
Senior Research Leader, Charles River
If you would like to learn more about SAMDI Tech’s innovative approach to drug discovery, including our label-free and high-throughput
SAMDI-MS technology, fill out the form to schedule time to discuss with us.